Recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Clinical trials for Recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) explained in plain language.

Never miss a new study

Get alerted when new Recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) trials appear

Sign up with your email to follow new studies for Recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could changing when chemo is given boost immunotherapy for head and neck cancer?

Disease control Recruiting now

This phase 2 trial is testing a new way of giving chemotherapy along with the immunotherapy drug pembrolizumab (Keytruda) for people with advanced head and neck cancer that has come back or spread. The idea is that giving chemo in short, spaced-out pulses after immunotherapy migh…

Matched conditions: RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (R/M HNSCC)

Phase 2 • Sponsor: Dan Zandberg • Aim: Disease control

Last updated Jun 27, 2026 09:03 UTC

Recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Get alerted when new Recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) trials appear

Could changing when chemo is given boost immunotherapy for head and neck cancer?